Schisandrin B prevents ulcerative colitis and colitis-associated-cancer by activating focal adhesion kinase and influence on gut microbiota in an in vivo and in vitro model

Jiani Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Luo(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Qiuhua Cao(China Pharmaceutical University), Ran Qi(First Affiliated Hospital of Henan University of Science and Technology), Cheng Chen(Nanjing Agricultural University), Fei Quan(China Pharmaceutical University), Yuan Lu(China Pharmaceutical University), Weiyan Tao(China Pharmaceutical University), Kaiyong Hu(China Pharmaceutical University), Yong Yang(Guilin Medical University), Xin Chen(China Pharmaceutical University), Rui Sun(Westlake University), Sen Zhao(Hebei Medical University), Xinghua Gao(First Hospital of China Medical University), Lihua He(China Pharmaceutical University), Dong Ding(Zhengzhou University), Zhisen Yang, Zhen Chen(Ningbo University), Dandan Zhao(University of Louisville), Duowei Wang(China Pharmaceutical University)
European Journal of Pharmacology
April 2, 2019
Cited by 37


Related Papers